Back to UBS Group AG UBS Group AG

CRMDCRMD
Showing 8 of 30 quarters

Position history for UBS Group AGUBS Group AG's holdings in CORMEDIX INC

UBS Group AG holds 1.9M shares of CRMD (CORMEDIX INC), worth $14.7M as of 2026-Q2. The position was increased (+22.1% shares). CRMD represents 0.0% of UBS Group AG's portfolio.

Current Value

$14.7M

Current Shares

1.9M

Total Value Change

+$14.4M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.9M
+22.1%
$14.7M0.0%$7.85
34
2026-Q1
Increased
1.5M
+141.8%
$10.4M0.0%$6.91
45
2025-Q4
Decreased
636,035
-41.7%
$7.4M0.0%$12.48
0
2025-Q3
Increased
1.1M
+295.3%
$12.7M0.0%$11.85
45
2025-Q2
Decreased
275,944
-54.2%
$3.4M0.0%$12.50
0
2025-Q1
Increased
602,534
+58.6%
$3.7M0.0%$6.74
38
2024-Q4
Increased
379,868
+861.3%
$3.1M0.0%$8.10
43
2024-Q3
Increased
39,516
+7.3%
$319,2890.0%$8.05
25

Other major holders of CRMD: Steward Partners Investment Advisory, LLC, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used